David A. Gorelick MD
Addiction
Professor of Psychiatry, University of Maryland School of Medicine Editor-in-Chief, Journal of Cannabis Research
Join to View Full Profile
5500 Nathan Shock DrBaltimore, MD 21224
Phone+1 410-550-1478
Fax+1 410-550-1528
Dr. Gorelick is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- David Gorelick, MD is a psychiatrist based in Baltimore, MD with a subspecialty in addiction. His medical training was completed at the Albert Einstein College of Medicine and residency at the UCLA David Geffen School of Medicine/UCLA Medical Center. He currently serves as a professor at the University of Maryland School of Medicine, editor-in-chief of the Journal of Cannabis Research, and a member of the Maryland Cannabis Public Health Advisory Council. Dr. Gorelick has published more than 200 papers in peer-reviewed medical journals and has designed and conducted numerous phase I and II clinical trials related to addiction and its treatmt. His work focuses on treatment of substance use disorders and comorbidity with other psychiatric disorders, such as schizophrenia.
Education & Training
UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Psychiatry, 1977 - 1980
UCLA-VA Greater Los AngelesInternship, Internal Medicine, 1976 - 1977
Albert Einstein College of MedicineClass of 1976
Certifications & Licensure
MD State Medical License 1989 - 2026
CA State Medical License 1977 - 2025
American Board of Psychiatry and Neurology Psychiatry
Clinical Trials
- Risk Perception in Drug-Dependent Adults With and Without Schizophrenia Start of enrollment: 2009 Aug 18
- Pilot Study of Repetitive Transcranial Magnetic Stimulation in Cocaine Craving Start of enrollment: 2010 Oct 11
- Quiting Marijuana Use: Self-report Study of Quitting Straegies and Withdrawal Symptoms Start of enrollment: 2005 Nov 08
Publications & Presentations
PubMed
- 5 citationsClozapine and neutrophil response in patients of African descent: A six-month, multinational, prospective, open-label clinical trial.Deanna L Kelly, Matthew Glassman, Ikwunga Wonodi, Gopal Vyas, Charles M Richardson
Schizophrenia Research. 2024-06-01 - 8 citationsCannabis-Related Disorders and Toxic Effects.David A Gorelick
The New England Journal of Medicine. 2023-12-14 - 8 citationsA randomized, double-blind, placebo-controlled, pharmacogenetic study of ondansetron for treating alcohol use disorder.Chamindi Seneviratne, David A Gorelick, Kevin G Lynch, Clayton Brown, Danielle Romer
Alcoholism, Clinical and Experimental Research. 2022-10-01
Other
- Cocaine abuse and dependence in adultsGorelick DA
http://www.uptodate.com/contents/cocaine-abuse-and-dependence-in-adults
UpToDate, Wolters Kluwer Health - 2011-12-19
Press Mentions
Legalization of Marijuana Could Lead to Public Health Concerns, Study SuggestsJanuary 1st, 2020- Counseling plus Buprenorphine–Naloxone Maintenance Therapy for Opioid DependenceJuly 27th, 2006
Stop Smoking Now!! See the 9 Side Effects of MarijuanaFebruary 25th, 2017- Join now to see all
Grant Support
- Identification Of Factors Associated With Response To Drugs And TreatmentNational Institute On Drug Abuse2009–2010
- Development Of New Pharmacologic And Biologic Treatments For Drug DependenceNational Institute On Drug Abuse2009–2010
- Development Of New Pharmacologic And Biologic Treatments For Drug DependenceNational Institute On Drug Abuse2007–2008
- Identification Of Factors Associated With Response To Drugs And TreatmentNational Institute On Drug Abuse1993–2008
- Development Of New Pharmacologic And Biologic TreatmentsNational Institute On Drug Abuse2006
- Identification Of Factors Associated With Response To DRNational Institute On Drug Abuse2002–2006
- Identification Of Factor Associated W/ Response To DrugsNational Institute On Drug Abuse2005
- Development Of New Pharmacologic And Biologic TreatmentsNational Institute On Drug Abuse2003–2005
- Development Of New Pharmacologic And Biologic TreatmentNational Institute On Drug Abuse2002
- New Treatment For Drug DependenceNational Institute On Drug Abuse2001
- Factors Associated With Response To Drugs And TreatmentNational Institute On Drug Abuse2001
- Development Of New Pharmacologic And Biologic Treatment For Drug DependenceNational Institute On Drug Abuse1993–2000
Professional Memberships
- Fellow
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
